Clovis Oncology, Inc. company info

CIK 1466301
IRS Number 900475355
State of incorporation DE
Business address 5500 FLATIRON PARKWAY
SUITE 100
BOULDER
CO
80301
Mail address 5500 FLATIRON PARKWAY
SUITE 100
BOULDER
CO
80301

Short summary

Clovis Oncology, Inc. is a Colorado company, with head office located at 5500 Flatiron Parkway Boulder, Colorado 80301. In 2018 the company owned a total of 784.62 million USD worth of assets, including 467.08 million USD worth of current assets. 2017 was the year when the company amassed the most assets.

Clovis Oncology, Inc. Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Selling, General and Administrative Expense 21.4630.5240.73138.91175.78
Operating Expenses 54.5973.7883.77172.08376.72372.81293.14429.20
Operating Income (Loss) -38.63-54.59-73.78-83.77-158.46-376.72-372.73-237.63-333.81
Interest expense 2.60
Other Nonoperating Income (Expense) 0.80-0.96-0.23-0.18-0.240.420.633.647.92
Income Tax Expense (Benefit) 0.03-0.030.052.31-29.08-32.03-3.580.61
Net income -37.83-55.57-73.98-84.53-160.03-352.86-349.14-346.40-368.01

Clovis Oncology, Inc. Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 57.3126.87176.90372.24273.23236.26228.38491.79468.32123.31
Available-for-sale Securities, Current 141.38150.12179.7499.53
Accounts Receivable, Net, Current 01.1412.3016.10
Inventories 6.4862.9924.99
Property, Plant and Equipment, Gross 2.171.591.683.796.747.107.7031.84
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.270.510.731.081.792.663.695.32
Goodwill 74.2260.8060.6162.0263.4863.07
Intangible Assets, Net (Excluding Goodwill) 239.22195.98101.5020.3053.4865.81
Other Assets, Noncurrent 0.040.754.5114.692.8747.6522.5321.20
Total assets 179.90375.22598.88663.00467.99849.90967.73784.62
Current assets 177.92373.44279.64388.20399.54715.77768.62467.08
Accounts payable 1.401.592.895.5315.0113.3615.9043.29
Taxes Payable, Current 0.660.100.92
Total current liabilities 9.8512.0124.9762.4372.86219.3876.62106.42
Long-term Debt 587.50
Deferred income taxes 75.1161.540.330.630.37
Total liabilities 12.50157.28463.33355.15506.10655.38709.77
Common Stock, Value, Issued 0.030.030.030.030.040.050.050.05
Retained Earnings (Accumulated Deficit) -334.50-563.72-994.62-1,364.89-1,653.97-1,929.51
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.050.052.86-41.91-45.05-44.31-44.05-44.56

Clovis Oncology, Inc. Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -37.83-55.57-73.98-84.53-160.03-352.86-349.14-346.40-368.01
Depreciation 0.080.190.350.250.440.801.1012
Amortization of Intangible Assets 3.4100.05
Depreciation and amortization 0.350.254.220.761.142.504.60
Deferred Income Tax Expense (Benefit) 0.76-29.08-32.10-3.220
Accounts receivable 000.126.063.37
Inventories 0027.5149.94
Accounts payable 0.871.66-0.760.96-1.378.11-1.545.645.77
Net Cash Provided by (Used in) Operating Activities -34.01-39.83-65.38-253.07-266.68-260.90-366.00
Payments to Acquire Property, Plant, and Equipment 0.770.451.060.122.293.040.770.499.24
Payments to Acquire Businesses, Net of Cash Acquired 9.91
Net Cash Provided by (Used in) Investing Activities -12.829.170.94-254.58199.30-54.10-264.24
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9.170.94-10.03-2.29-254.58199.30
Proceeds from Issuance of Common Stock 129.3669.98259.070298.510545.8493.89
Net Cash Provided by (Used in) Financing Activities 0.03158.3570.29304.485.18562.08388.46
Cash and Cash Equivalents, Period Increase (Decrease) -46.80127.735.86179.13159.45-203.92-62.57248.01